A STUDY ON BANNED FIXED DOSE COMBINATIONS IN INDIA
Dhiraj Kumar*, Kashish Bhardwaj, Ankit Sharma, Sazid, Shivani and Saurabh
ABSTRACT
In the current scenario India is a large center of banned drugs. There are large number of banned drugs present in Indian market which is banned in foreign countries. The market of banned drug is increasing day by day in the developing countries due to lack of prescriber awareness, low enforcement, laxity of drug control authorities and corruption. The main purpose of making all medicine is treatment and prevention from diseases. As we know that every drug has some side effect but banned drugs have more side effects as compared to other drugs. The most common banned drug in world-wide is present in the market of India and other developing countries. For example: nimesulide, furazolidone, phenyl-propanolamine etc. due to their side effects major organs or systems of the body are harmed and sometimes it causes death of patient. The use of fixed dose combination is trending now a days but a large number of fixed dose combinations is banned in India due to their side effects and no effects on the patient. In this study our main focus will be on the case study of some fixed dose combination of drugs which are banned by Indian government including their reason of banning, uses and all other information.
[Full Text Article] [Download Certificate]